Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 1, 2022.
Article Versions
- Latest version (June 15, 2022 - 04:00).
- You are currently viewing a Latest version of this article (October 1, 2022 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2022 The Journal of Rheumatology
Author Information
- Signe Holm Nielsen,
- Andrew Stahly,
- Emilie H. Regner,
- Anne-Christine Bay-Jensen,
- Morten A. Karsdal and
- Kristine A. Kuhn
-
This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden).
S. Holm Nielsen, PhD, Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, and ImmunoScience, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark; A. Stahly, MD, E.H. Regner, MD, PhD, K.A. Kuhn, MD, PhD, Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; A.C. Bay-Jensen, PhD, M.A. Karsdal, PhD, Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark.
SHN, ACBJ, and MAK are full-time employees at Nordic Bioscience A/S.
Nordic Bioscience is a privately-owned, small- and medium-sized enterprise partly focused on the development of biomarkers. None of the authors received fees, bonuses, or other benefits for the work described in the manuscript. SHN, ACBJ, and MAK hold stocks in Nordic Bioscience A/S. The remaining authors declare no conflicts of interest relevant to this article.
Address correspondence to Dr. S. Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark. Email: shn@nordicbio.com.
Accepted for publication July 8, 2022.